Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Current Deferred Revenue (2009 - 2011)

Updated

Protagenic Therapeutics, Inc.new (PTIX) reported Current Deferred Revenue of $542,000 for fiscal Q3 2013 (quarter ended Sep 30, 2011), down 12.2% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Current Deferred Revenue (2009 - 2011) Analysis & Trends

At the end of FY2010 (ended Dec 31, 2010), Protagenic Therapeutics, Inc.new posted Current Deferred Revenue of $274,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,286.92 Bn 1,260.54 Bn 20.46 Bn
2 Johnson & Johnson 686.05 Bn 605.91 Bn 17.30 Bn
3 AbbVie 523.52 Bn 491.53 Bn 13.12 Bn
4 Merck 361.19 Bn 324.13 Bn 13.19 Bn
5 Novartis Ag 313.37 Bn 286.61 Bn -
6 Astrazeneca 286.61 Bn 260.13 Bn 13.26 Bn
7 Amgen 252.56 Bn 204.21 Bn 7.58 Bn
8 Gilead Sciences 210.02 Bn 185.12 Bn 6.73 Bn
9 Pfizer 164.90 Bn 112.26 Bn 12.56 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 542,000.00
Jun 30, 2011 617,000.00
Dec 31, 2010 274,000.00
Mar 31, 2009 1.61 Mn
API Access

Protagenic Therapeutics, Inc.new Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PTIX&period=max&api_key=YOUR_API_KEY